Paris, I0CIK 11214044 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
8 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Meiragtx Hldgs PLC | 12.20M | $96.97M | 31.2% | 0 | Held |
| 2 | Inhibrx Biosciences Inc | 1.16M | $91.48M | 29.5% | 0 | Held |
| 3 | Novavax Inc | 6.88M | $46.24M | 14.9% | 0 | Held |
| 4 | Anaptysbio Inc |
| 821.9K |
| $39.85M |
| 12.8% |
| 0 |
| Held |
| 5 | Immuneering Corp | 2.71M | $17.82M | 5.7% | 0 | Held |
| 6 | Maplight Therapeutics Inc | 912.0K | $16.02M | 5.2% | +912.0K | New |
| 7 | Eledon Pharmaceuticals Inc | 815.0K | $1.23M | 0.4% | 0 | Held |
| 8 | Q32 Bio Inc | 244.1K | $810.4K | 0.3% | 0 | Held |